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The stem-loop binding protein (SLBP1) binds the 39 stem-loop of histone pre-mRNA and is
required for efficient processing of histone transcripts in the nucleus. We examined the localiza-
tion of SLBP1 in the germinal vesicle of Xenopus laevis oocytes. In spread preparations of germinal
vesicle contents, an anti-SLBP1 antibody stained coiled bodies and specific chromosomal loci,
including terminal granules, axial granules, and some loops. After injection of myc-tagged SLBP1
transcripts into the oocyte cytoplasm, newly translated myc-SLBP1 protein was detectable in
coiled bodies within 4 h and in terminal and axial granules by 8 h. To identify the region(s) of
SLBP1 necessary for subnuclear localization, we subcloned various parts of the SLBP1 cDNA and
injected transcripts of these into the cytoplasm of oocytes. We determined that 113 amino acids
at the carboxy terminus of SLBP1 are sufficient for coiled body localization and that disruption of
a previously defined RNA-binding domain did not alter this localization. Coiled bodies also
contain the U7 small nuclear ribonucleoprotein particle (snRNP), which participates in cleavage
of the 39 end of histone pre-mRNA. The colocalization of SLBP1 and the U7 snRNP in the coiled
body suggests coordinated control of their functions, perhaps through a larger histone-processing
particle. Some coiled bodies are attached to the lampbrush chromosomes at the histone gene loci,
consistent with the view that coiled bodies in the oocyte recruit histone-processing factors to the
sites of histone pre-mRNA transcription. The non-histone chromosomal sites at which SLBP1 is
found include the genes coding for 5 S rRNA, U1 snRNA, and U2 snRNA, suggesting a wider
role for SLBP1 in the biosynthesis of small non-spliced RNAs.
INTRODUCTION
Before being transported to the cytoplasm, histone
pre-mRNAs in higher eukaryotes undergo a unique
processing reaction involving a single endonucleolytic
cleavage to form the 39 end of the histone mRNA
(Birchmeier et al., 1984; Krieg and Melton, 1984; Gick et
al., 1986). This cleavage is directed by two conserved
sequences within the pre-mRNA, one upstream and
one downstream of the cleavage site. The downstream
region binds the U7 small nuclear ribonucleoprotein
particle (snRNP)1 via complementarity to part of the
U7 snRNA (Strub et al., 1984; Schaufele et al., 1986;
Bond et al., 1991). The upstream sequence is a stem-
loop that binds an additional factor or factors required
for processing (Mowry and Steitz, 1987; Vasserot et al.,
1989; Melin et al., 1992). Recently the yeast three-hy-
brid system (SenGupta et al., 1996) has been used to
identify the human stem-loop binding protein (SLBP1)
(Wang et al., 1996) or the hairpin-binding protein
(HBP) (Martin et al., 1997). Human, mouse, and Xeno-
pus SLBP1 are closely related in sequence but are not
similar to other known proteins (Wang et al., 1996). A
novel RNA-binding domain has been identified in
SLBP1 by deletion analysis. SLBP1 binds to the histone
pre-mRNA in the nucleus, probably during transcrip-
tion, and accompanies the mature histone mRNA to
‡ Corresponding author: Department of Embryology, Carnegie
Institution, 115 West University Parkway, Baltimore, MD 21210.
E-mail address: gall@mail1.ciwemb.edu.
1 Abbreviations used: DAPI, 49,6-diamidino-2-phenylindole; DIC,
differential interference contrast; GV, germinal vesicle; NLS,
nuclear localization signal; PBS, phosphate-buffered saline;
SLBP1, stem-loop binding protein; snRNP, small nuclear ribo-
nucleoprotein particle; TMG, trimethylguanosine.
© 1999 by The American Society for Cell Biology 487
the cytoplasm, where the complex associates with
polyribosomes (Dominski et al., 1995; Hanson et al.,
1996). In the Xenopus oocyte, unlike in somatic cells,
histone mRNA is stored in the cytoplasm and not
translated during the long growth phase (Woodland
and Adamson, 1977; Woodland, 1980). In the stored
form of histone mRNA, SLBP1 is replaced by another
stem-loop binding protein, SLBP2, which is oocyte-
specific (Wang et al., 1999). The RNA-binding domains
of SLBP1 and SLBP2 are similar, but otherwise the two
proteins are not obviously related in sequence.
We have examined the localization of SLBP1 in the
oocyte nucleus or germinal vesicle (GV) of Xenopus.
Because of its large size, up to 400 mm in diameter, the
GV has been particularly useful for both cytological
and molecular analyses of RNA transcription and pro-
cessing. The major structural components in a GV are
the giant lampbrush chromosomes, ;1500 extrachro-
mosomal nucleoli, several thousand small granules
(1–4 mm in diameter) known as B-snurposomes, and
50–100 coiled bodies (Wu et al., 1991). Each of these
components is involved in some aspect of RNA tran-
scription or processing. Coiled bodies are of particular
interest in the present context, because of their asso-
ciation with histone pre-mRNA processing. In both
oocytes (Wu and Gall, 1993; Wu et al., 1996) and so-
matic nuclei (Bauer et al., 1994; Frey and Matera, 1995),
coiled bodies are the only structures in which U7
snRNA has been demonstrated. Furthermore, in the
GV some coiled bodies are attached to the lampbrush
chromosomes at the histone gene loci (Gall et al., 1981;
Callan et al., 1991), and a similar association is true in
interphase HeLa nuclei (Frey and Matera, 1995). These
facts suggest that coiled bodies are involved in the
recruitment of processing factors to the sites of histone
pre-mRNA transcription and perhaps in the assembly
of processing complexes (Wu et al., 1996; Bellini and
Gall, 1998). In support of this hypothesis, we find that
an antibody against SLBP1 stains coiled bodies in GVs
of Xenopus. The distribution of SLBP1 within the
coiled body is almost identical to that of the U7
snRNP. We have confirmed the localization by dem-
onstrating that epitope-tagged SLBP1 is targeted to
coiled bodies, and we have shown that 113 amino
acids from the carboxy terminus of SLBP1 are suffi-
cient for targeting to coiled bodies, even though the
RNA-binding domain is disrupted.
MATERIALS AND METHODS
Oocytes and GV Spreads
A piece of ovary was surgically removed from a female Xenopus
laevis anesthetized in 0.15% tricaine methane sulfonate or MS222
(A5040; Sigma, St. Louis, MO). The isolated ovary was held in
Ca21-free OR2 saline (Wallace et al., 1973) containing 0.2% collage-
nase, type II from Clostridium histolyticum (C6885; Sigma), to defol-
liculate and separate individual oocytes. The defolliculated oocytes
were held at 18°C in OR2 saline until used for injections or GV
spreads. GV spreads were made as described previously (Gall,
1998). Centrifuged preparations were fixed in 2% paraformaldehyde
in phosphate-buffered saline (PBS; 0.14 M NaCl, 2.7 mM KCl, 4.3
mM Na2HPO4, 1.5 mM KH2PO4, pH 7.0) for 1 h or longer. GV
spreads used for in situ hybridization were held in 70% ethanol for
at least 1 h.
Immunofluorescence
GV spreads were rinsed in PBS and blocked with 10% horse serum
in PBS for 15 min. Spreads were incubated with primary antibody
for 1 h at room temperature and then washed in three changes of
PBS for a total of 15 min. Secondary antibody was applied for 1 h at
room temperature, and slides were washed again in three changes
of PBS. mAbs were used as undiluted culture supernate or diluted
1:3 in 10% horse serum (mAb 9E10), whereas rabbit sera were
diluted 1:200 to 1:1000 with 10% horse serum. Secondary antibodies
were Cy3- or fluorescein-conjugated donkey anti-rabbit or donkey
anti-mouse IgG (Jackson ImmunoResearch, West Grove, PA) used
at a dilution of 1:500 or 1:250, respectively. In double-labeling ex-
periments, the primary antibodies and their corresponding second-
aries were applied successively. Preparations were mounted in 50%
glycerol containing phenylenediamine at 1 mg/ml and 49,6-dia-
midino-2-phenylindole (DAPI) at 1 mg/ml. Antibodies used for
immunofluorescence included X16C, a rabbit polyclonal serum
raised against a 17-amino acid peptide from the carboxy terminus of
SLBP1 and purified by selection with protein A (Wang et al., 1996),
mAb H1 against Xenopus coilin (also called SPH-1) (Tuma et al.,
1993), mAb K121 against the trimethylguanosine (TMG) cap of
snRNAs (Krainer, 1988), mAb H14 against RNA polymerase II
(Bregman et al., 1995), and mAb 9E10 against the c-myc epitope
(Evan et al., 1985). Peptide-1, used for production of antibody X16C,
was KDAFDLEPCFIEEELLS; peptide-2, derived from SLBP2 and
used here as a nonspecific competitor, was KGHTNDYTYPHWIGL.
Subcloning of SLBP1 and Deletions
Xenopus SLBP1 was amplified by PCR from the original pGad10
cDNA clone described by Wang et al. (1996) and subcloned into a
derivative of the MT6 vector that contains six copies of the c-myc
epitope (Roth et al., 1991) and the SV40 nuclear localization signal
(NLS) (Wu et al., 1994). PCR primers were designed to amplify the
coding region and ;300 nucleotides of the 39 untranslated region.
The primers were JA31 and JA36. Deletions of SLBP1 were ampli-
fied with PCR primers and subcloned into the same vector. The
deletions were as follows (see Figure 7): myc-SLBP1-N: amino acids
1–122 (primers JA31 and JA39); myc-SLBP1-NR: amino acids 1–195
(primers JA31 and JA40); myc-SLBP1-RC: amino acids 123–253
(primers JA38 and JA36); myc-SLBP1-RCD: amino acids 140–253
(primers JA32 and JA36); myc-SLBP1-R: amino acids 123–195 (prim-
ers JA38 and JA40); myc-SLBP1-C: amino acids 196–253 (primers
JA41 and JA36); myc-SLBP1-NC: constructed by subcloning myc-
SLBP1-N and myc-SLBP1-C together at the in-frame BamHI site
created by the primers.
The primers were as follows: JA31: 59-GC 1 BamHI 1 amino acids
25–8; JA32: 59-GC 1 BamHI 1 G 1 amino acids 140–146; JA36:
59-GC 1 XbaI 1 GAAAAAGGCTTATACCGTGCC (;300 nucleo-
tides beyond the SLBP1 translation stop codon); JA38: 59-GC 1
BamHI 1 amino acids 123–129; JA39: 59-GC 1 BamHI 1 CCTCCAT-
GTGTAGATGAATC; JA40: 59-GGC 1 XbaI 1 GTCCCACTGATG-
TAGAGCAATTCTCC; JA41: 59-GC 1 BamHI 1 amino acids 196–
206.
Injection of myc-tagged SLBP1 Transcripts
Capped sense-strand transcripts were synthesized with T3 RNA
polymerase (Stratagene, La Jolla, CA) from 1 mg of the appropriate
subclone after linearization with XbaI. The RNA was analyzed for
size on a 1% agarose, 1.3% formaldehyde gel. Aliquots were pre-
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cipitated and resuspended at 1 mg/ml; 23 nl of RNA solution was
injected into the cytoplasm of defolliculated oocytes using a Drum-
mond Nanoject injection apparatus (Drummond Scientific,
Broomall, PA). Injected oocytes were transferred to OR2 saline and
stored at 18°C until used for GV spreads or Western analysis.
myc-tagged SLBP1 was detected on GV spreads and Western blots
with mAb 9E10, which is specific for the c-myc epitope (Evan et al.,
1985).
Western Blotting
Isolated GVs were centrifuged to separate organelles from the nu-
cleoplasm. All samples were boiled with the appropriate amount of
23 gel buffer for 5–10 min and electrophoresed on a 10% polyacryl-
amide-SDS gel (Laemmli, 1970). Proteins were electroeluted from
the gel onto polyvinylidene fluoride membranes (Immobilon P;
Millipore, Bedford, MA). Membranes were blocked in 5% dried
milk plus 0.05% Tween in PBS and incubated with the appropriate
primary antibody. Detection of signal was by chemifluorescence
(ECF kit; Amersham, Arlington Heights, IL) with the Storm 860
Scanner (Molecular Dynamics, Sunnyvale, CA).
RESULTS
SLBP1 Is Present in Coiled Bodies and Specific
Chromosomal Loci
Cytological studies of SLBP1 in the Xenopus GV were
performed primarily with antibody X16C, a rabbit
polyclonal serum raised against a 17-amino acid pep-
tide from the carboxy terminus of SLBP1 and purified
by selection with protein A (Wang et al., 1996). The
antibody was used to stain organelles isolated from
single GVs. The nuclear envelope of a manually iso-
lated GV was removed with forceps, and the gelati-
nous contents were allowed to spread on a standard
microscope slide (Gall, 1998). After centrifugation of
the slide, the soluble nucleoplasm was washed away,
leaving the chromosomes, nucleoli, B-snurposomes,
and coiled bodies attached to the slide (Wu et al.,
1991). Coiled bodies in the oocyte are large structures
up to 10 mm in diameter, divided into three morpho-
logical compartments (Figure 1). Preparations immu-
nostained with serum X16C showed a strong reaction
in coiled bodies. The stain was clearly present in the
matrix but excluded from both the B-snurposomes on
the surface and the internal B-like inclusions (Figure 2,
A–H). The unstained B-snurposomes and inclusions
were visible in the differential interference contrast
(DIC) image (Figure 2, A, E, and I). All coiled bodies in
the GV stained with SLBP1, including those attached
to the lampbrush chromosomes at the histone gene
loci (Figure 2M). To identify coiled bodies unambigu-
ously, we costained GV spreads with serum X16C and
mAb H1 against Xenopus coilin (also called SPH1)
(Tuma et al., 1993). The two antibodies stained with
essentially the same pattern (Figure 2, A–H). GV
spreads were also costained with serum X16C and
mAb K121, which is specific for the TMG cap of
snRNAs (Krainer, 1988). Earlier experiments demon-
strated that mAb K121 stains U7 snRNA in the matrix
of the coiled body and splicing snRNAs in the B-
snurposomes and inclusions (Wu et al., 1991; Wu and
Gall, 1993; Bellini and Gall, 1998). Figure 2, I and J,
shows that X16C and K121 both stain the matrix of the
coiled body, whereas only K121 stains the B-snurpo-
somes and the inclusion.
Because X16C is a polyclonal rabbit serum that
might cross-react with proteins of unknown nature in
the GV, we tested its specificity by immunostaining in
the presence of two peptides: peptide-1, the 17-amino
acid sequence used for immunization, and peptide-2,
an unrelated sequence derived from SLBP2. Peptide-2
had no effect on the staining of X16C. By contrast,
peptide-1 caused a marked reduction in the staining of
coiled bodies, the extent of which was determined by
measuring the intensity of stain with a charge-coupled
device (CCD) camera. Figure 3A is a graph of fluores-
cence intensity versus coiled body volume for prepa-
rations stained with secondary antibody only or with
X16C in the presence of peptide-1 or peptide-2. Pep-
Figure 1. Diagram of a coiled body from a Xenopus GV and a list
of some of its molecular components. The coiled body consists of
three parts: a matrix, B-snurposomes attached to the surface, and
B-like inclusions. The number of attached B-snurposomes and in-
clusions is variable, and they may be absent. The attached B-snur-
posomes are identical in all respects to the hundreds of free B-
snurposomes in the nucleoplasm. The inclusions are generally
smaller than B-snurposomes but are otherwise identical. The terms
coiled body and sphere are used synonymously. In some previous
publications (Wu et al., 1996), the term C-snurposome referred to the
matrix and inclusions only.
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tide-1 reduced the staining of X16C approximately
sevenfold, to a level only slightly above the back-
ground because of secondary antibody alone (Figure
3B). These data support the assumption that X16C
staining in coiled bodies is caused by SLBP1. In sum-
mary, immunostaining with X16C demonstrates that
SLBP1 occurs in the matrix of oocyte coiled bodies,
where it is colocalized with coilin and the U7 snRNP.
This finding strengthens the view that coiled bodies
are involved in some aspect of histone pre-mRNA
processing. Because some coiled bodies are attached to
the lampbrush chromosomes at the histone gene loci,
an attractive hypothesis is that coiled bodies recruit
processing components to the site of histone gene
transcription, where they may be assembled into func-
tional processing complexes (Wu et al., 1996; Bellini
and Gall, 1998).
Serum X16C also stained several chromosomal loci:
all terminal granules (Figure 2, K, M, and N), several
so-called axial granules (Figure 2, K and N), and ap-
proximately a dozen sets of specific transcription
loops (Figure 2, L–N). In each case, staining was es-
sentially abolished by pretreatment of the antibody
with peptide-1 against which it was raised. Although
it was easy to rationalize the colocalization of SLBP1
with the U7 snRNP in coiled bodies, staining of ter-
Figure 2 (facing page). Localization of SLBP1 in the Xenopus GV by immunofluorescence. Stained images were taken with a Leica
(Heidelberg, Germany) TCS NT confocal microscope. (A–D) DIC and immunofluorescence images of two coiled bodies, a nucleolus, and
several B-snurposomes double-stained with serum X16C against SLBP1 (fluorescein) and mAb H1 against Xenopus coilin (Cy3). SLBP1 and
coilin are both limited to the matrix of the coiled body, being excluded from the B-snurposomes on the surface (left coiled body) and the
internal B-like inclusion (right coiled body). (E–H) Higher magnification of a similar coiled body that has two B-snurposomes on the surface
and two inclusions. Note the patchy distribution of SLBP1 staining and the lack of complete correspondence between the SLBP1 and coilin
stains in the merged image. (I and J) Coiled body double-stained with serum X16C for SLBP1 (Cy3) and mAb K121 for the TMG cap of
snRNAs (fluorescein). mAb K121 detects U7 snRNA in the matrix of the coiled body (Bellini and Gall, 1998) and splicing snRNAs in the
B-snurposomes and inclusions (Wu et al., 1991). (K–N) Lampbrush chromosomes double-stained with serum X16C for SLBP1 (Cy3) and mAb
K121 for TMG (fluorescein). The nascent transcripts on almost all chromosome loops are associated with splicing snRNAs and hence stain
strongly for TMG. Those few loops that stain red with serum X16C do not stain with mAb K121, presumably because they lack splicing
snRNAs (open arrowheads in L–N). Terminal granules stain only with X16C (filled arrowheads in K, M, and N); the same is true of axial
granules (arrows in K and N). M shows chromosome 9, which has a coiled body attached at the histone gene locus (arrow). In this case the
single coiled body joins the two homologous chromosomes; in other cases each homologue may have its own coiled body. The coiled body
is yellow, because it stains with both antibodies.
Figure 3. Staining of coiled bodies with anti-SLBP1 serum X16C is reduced by treatment with peptide-1, against which the antibody was
raised. (A) Images of stained coiled bodies were taken with a charge-coupled device (CCD) camera; the total fluorescence from individual
coiled bodies was then measured as the sum of pixel values and plotted as a function of coiled body volume. The linear relationship shows
that the amount of SLBP1 in a coiled body is proportional to its volume. Staining was markedly reduced by previous treatment of the
antibody with peptide-1, whereas the unrelated peptide-2 had no effect. (B) The slopes of the curves in A were determined and compared.
The slope represents the amount of stain per unit volume and is assumed to be a measure of stain per unit of SLBP1.
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minal granules, axial granules, and specific loops
came as a surprise, because these structures have no
known association with histone genes or histone pre-
mRNA transcription and processing. Terminal and
axial granules were originally described on the basis
of their morphology and staining characteristics (Cal-
lan, 1986, pp. 92–95; Pyne et al., 1995; Hock et al., 1996).
They consist of small masses of DAPI-negative mate-
rial attached to DAPI-positive chromomeres; terminal
granules occur at the very tip of the chromosome,
whereas axial granules occupy interstitial positions.
Both terminal and axial granules are recognizable in
Xenopus lampbrush chromosomes by their intense
staining with antibodies against polymerase II (Gall
and Murphy, 1998). Terminal granules are found at
the end of the long arm on 15 of the 18 Xenopus
lampbrush bivalents, and all of these sites stain with
serum X16C. Previously these 15 sites were shown by
in situ hybridization to be associated with oocyte-type
5S rRNA genes (Pardue et al., 1973; Callan et al., 1988).
For the most part, the genes at the sites of axial
granules are unknown, but we have found that both
the U1 and U2 snRNA genes are associated with axial
granules. In Xenopus the U1 and U2 genes are ar-
ranged in tandem arrays. There are ;500 copies of the
U1 snRNA genes per haploid genome (Lund et al.,
1984) and ;500–1000 copies of U2 (Mattaj and Zeller,
1983). The highly repetitive nature of these genes
greatly facilitated their detection on lampbrush chro-
mosomes. Fluorescence in situ hybridization with a
biotinylated probe revealed that U1 genes occur at an
axial granule on the long arm of chromosome 2 (our
unpublished data). As shown by immunofluores-
cence, this axial granule also stains with serum X16C
against SLBP1 (Figure 2K, arrows). The U2 genes are
similarly situated at a single site associated with an
SLBP1(1) axial granule on the long arm of chromo-
some 11. In this case SLBP1(1) loops also occur at the
site (Figure 2N, open arrowheads). X16C stains several
other axial granules, about which we have no molec-
ular information; an example is that near the centro-
mere of chromosome 11 (Figure 2N, arrow). Interest-
ingly, coiled bodies are attached at the U1 and U2 gene
sites in HeLa and HEp-2 cell nuclei (Frey and Matera,
1995; Smith et al., 1995; Matera, 1998). Although coiled
bodies as such are not present at these loci in the
Xenopus GV (Figure 2, K and N), the common factor
here may be SLBP1. That is, the association of coiled
bodies with the U1 and U2 genes in somatic nuclei
may be a mechanism for bringing SLBP1 (and other
molecules) to these sites.
A strong reaction with serum X16C was also ob-
served on specific loops on several lampbrush chro-
mosomes. Staining was limited to a small number of
loops at each site and was usually detectable on both
homologues (Figure 2, L–N). Although morphologi-
cally unremarkable, these loops share an unusual
characteristic; they do not have splicing factors asso-
ciated with their nascent transcripts. This is shown by
their failure to stain with mAb Y12, mAb SC35, and
mAb K121, which recognize, respectively, the Sm pro-
teins, members of the SR group of non-snRNP splicing
factors, and the TMG cap found on splicing snRNAs
(Figure 2, L–N). By contrast, the overwhelming major-
ity of lampbrush loops contain splicing machinery and
react strongly with these three antibodies (Figure 2,
K–N) (Wu et al., 1991).
Of several antibodies against SLBP1 available to us,
X16C gave the strongest immunofluorescent signal on
coiled bodies and chromosomes and had a particu-
larly low background on other nuclear organelles.
However, it reacted with several bands on Western
blots of GV proteins. Isolated GVs were centrifuged to
separate insoluble organelles (chromosomes, nucleoli,
B-snurposomes, and coiled bodies) from the soluble
nucleoplasm, and the fractions were electrophoresed
on a 10% SDS-polyacrylamide gel and transferred to
an Immobilon membrane for immunostaining. Anti-
body X16C reacted with several bands, one of which
had the mobility expected of SLBP1 (;40 kDa) (Figure
4, lanes 1 and 2). The 40 kDa band, but none of the
other bands, was competed by the SLBP1 peptide-1
(Figure 4, lanes 3 and 4), whereas the unrelated pep-
tide-2 had no effect on any bands (Figure 4, lanes 5 and
6). Most SLBP1 was in the soluble nucleoplasm, al-
though a detectable signal was seen in the insoluble
pellet. It is presumably this small amount of insoluble
SLBP1 that is detected by immunofluorescent staining
in coiled bodies and chromosomes. We do not know
Figure 4. Western blot of GV proteins probed with antibodies
against Xenopus SLBP1. GV contents were centrifuged to separate
the soluble nucleoplasm (S) from the pellet (P), which contains
chromosomes, nucleoli, B-snurposomes, and coiled bodies. (Lanes 1
and 2) Proteins from 50 GVs probed with antibody X16C. (Lanes 3
and 4) Proteins from 50 GVs probed with X16C in the presence of
peptide-1, against which the antibody was raised. A single band
with a mobility corresponding to SLBP1 (;40 kDa) is specifically
competed. (Lanes 5 and 6) Proteins from 50 GVs probed with X16C
in the presence of the unrelated peptide-2. (Lanes 7 and 8) Proteins
from 25 GVs probed with antibody X1, which is more specific for
SLBP1 on Western blots but gives poor immunofluorescent staining.
Molecular weight standards are on the left.
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the nature of the other bands that cross-react with
serum X16. Although most of the cross-reacting mate-
rial is in the soluble fraction and would be washed out
of the cytological preparations, some is in the insolu-
ble pellet and must be on the stained slides. It pre-
sumably contributes to the general background but
does not interfere with detection of SLBP1 itself. A
much cleaner Western blot was given by antibody X1
(Wang et al., 1999), an affinity-purified rabbit poly-
clonal serum that was raised against SLBP1 expressed
in Baculovirus (Figure 4, lanes 7 and 8). Unfortunately,
this antibody gave a high level of nonspecific staining
when used for immunofluorescence.
myc-tagged SLBP1 Is Targeted to Coiled Bodies and
to Terminal and Axial Granules of Chromosomes
To confirm the localizations derived from immunoflu-
orescence, we examined the intranuclear localization
of epitope-tagged SLBP1. A full-length SLBP1 cDNA
was subcloned into a vector that carried the T3 RNA
polymerase promoter, six copies of the c-myc epitope
(Roth et al., 1991), and the SV40 NLS (Wu et al., 1994).
Capped sense-strand transcripts were synthesized
with T3 RNA polymerase and injected into the cyto-
plasm of stage V–VI Xenopus oocytes. After incubation
for 24 h, oocytes were separated into GV and cytoplas-
mic fractions for Western analysis with mAb 9E10,
which is specific for the c-myc epitope. A single pro-
tein product migrating at ;50 kDa was present in GVs
of injected oocytes (Figure 5, lanes 1 and 2). The same
Western blot, when reprobed with antibody X1
against SLBP1, demonstrated both the endogenous
40-kDa SLBP1 and newly synthesized 50-kDa myc-
SLBP1 (Figure 5, lanes 3 and 4). There is somewhat
more newly synthesized than endogenous SLBP1 in
the GV at this time point.
GV spreads were prepared at various times from 2
to 24 h after injection of myc-SLBP1 transcripts. Within
4 h the matrix of coiled bodies was detectably stained
by anti-myc antibody, and at later times the staining
became increasingly strong (Figure 6, A and B). B-
snurposomes attached to the surface of the coiled bod-
ies, which are visible in the DIC image of Figure 6B,
did not stain. Thus, newly synthesized SLBP1 is rap-
idly and specifically targeted to the matrix of coiled
bodies. The anti-myc staining pattern in coiled bodies
of injected oocytes was essentially the same as that
seen with the X16C antibody in uninjected oocytes,
supporting the conclusion that X16C accurately de-
tects endogenous SLBP1 in coiled bodies.
During the first few hours after injection, staining
with anti-myc antibody was limited to the coiled bod-
ies. At later time points, all structures in the GV began
to show detectable label, especially the nucleoli and
the loops of the lampbrush chromosomes. The stain-
ing of loops was generalized and relatively weak. At
no time did we see highlighting of specific loops,
which was such a prominent feature of the staining
with antibody X16C. On the other hand, terminal and
axial granules did stand out above the increased level
of overall staining. An example is shown in Figure 6,
C and D. In this case two B-snurposomes are attached
to a chromosome very near a terminal granule. These
structures appear similar in the DIC image (Figure
6D), but the terminal granule is brighter than the
B-snurposomes after staining with anti-myc antibody
(Figure 6C). To provide certain identification of these
otherwise inconspicuous structures, some prepara-
tions were counterstained with mAb H14 against
RNA polymerase II, which gives an intense stain in
axial and terminal granules.
We interpret the strong staining of coiled bodies at
early time points after injection and the weak but
specific staining of terminal and axial granules at later
time points as indicative of the true intranuclear dis-
tribution of SLBP1. On the other hand, the high gen-
eralized staining of nucleoli and chromosome loops at
later time points is more problematic. Although it is
possible that newly expressed SLBP1 normally transits
these structures, it may be that nonspecific “sticking”
of myc-SLBP1 occurs during specimen preparation. An
advantage of the oocyte system, as compared with
Figure 5. Transcripts of full-length myc plus NLS–tagged SLBP1
were injected into the oocyte cytoplasm. Sixteen hours later, GVs
and cytoplasms (cyt) were manually isolated, and their proteins
were separated on an SDS-polyacrylamide gel. Western blots were
made with mAb 9E10 against the c-myc tag (lanes 1 and 2) or with
antibody X1 against SLBP1 (lanes 3 and 4). All myc-tagged SLBP1 is
found in the nucleus and is recognized by both antibodies at a
mobility corresponding to ;50 kDa. Antibody X1 also recognizes
endogenous SLBP1 in both nucleus and cytoplasm at a mobility of
;40 kDa. It also stains a minor cross-reacting band in both nucleus
and cytoplasm just below the heavy band of myc-SLBP1.
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transient transfections, is that the amount of newly
translated protein can be regulated to avoid high lev-
els of overexpression and consequent mislocalization.
Nevertheless, even in these experiments, in which the
total amount of new protein produced in 24 h is only
slightly more than the endogenous level, the rate of
new synthesis is well above normal levels and may
lead to spurious localization.
Amino Acids 140–253 Are Sufficient to Target SLBP1
to Coiled Bodies
We examined deletion constructs of SLBP1 to deter-
mine which region(s) of the protein is required for
targeting to coiled bodies. In the original description
of SLBP1, Wang et al. (1996) identified a 73-amino acid
RNA-binding domain (amino acids 123–195), which
was defined by its ability to cause a gel shift of the
stem-loop structure found at the 39 end of histone
pre-mRNA. Otherwise, there are no known motifs
with specific functions or similarities to other proteins
in the data bases. For this reason our analysis was
based on constructs that divided the molecule into
three segments: an amino-terminal fragment (amino
acids 1–122), the RNA-binding domain (amino acids
123–195), and a carboxy-terminal fragment (amino ac-
ids 196–253). Appropriate fragments were amplified
by PCR from the original pGAD10 clone and sub-
cloned into the MT6 vector plus the SV40 NLS. Be-
cause the NLS of SLBP1 has not been identified, the
addition of the SV40 NLS ensured that all deletion
constructs would be transported to the nucleus. The
constructs used for injection are shown in Figure 7A.
Capped, myc-tagged RNA was transcribed in vitro
and injected into the oocyte cytoplasm. GVs and cy-
toplasms were isolated after 8 h and prepared for
Western blotting with mAb 9E10 against the c-myc
epitope. As shown in Figure 7B, all constructs were
expressed at readily detectable levels in the oocyte and
were localized primarily to the GV.
GV spreads were also prepared 8 h after injection
and stained with mAb 9E10. Constructs that contained
the amino-terminal fragment (myc-SLBP1-N, amino
acids 1–122), the amino terminus plus the RNA-bind-
ing domain (myc-SLBP1-NR, amino acids 1–195), or
the RNA-binding domain alone (myc-SLBP1-R, amino
acids 123–195) failed to accumulate in any specific
structure (Figure 6, E and F). These results demon-
strated that the first two-thirds of the molecule did not
contain sufficient information for targeting to the
coiled bodies. However, constructs that contained
only the carboxy terminus (myc-SLBP1-C, amino acids
196–253) or the carboxy and amino termini together
Figure 6. Localization of myc plus NLS–tagged SLBP1 in GV spreads. Each pair of panels shows a DIC image and the corresponding
immunofluorescent image after staining with mAb 9E10 against the c-myc tag. (A and B) A single coiled body from an oocyte injected 8 h
previously with transcripts of full-length myc-SLBP1. The tagged protein accumulates in the matrix of the coiled body in a distinctly granular
pattern. (C and D) End of a chromosome 8 h after a similar injection. The solid arrowhead points to a stained terminal granule; the open
arrowheads point to two adjacent unstained B-snurposomes. (E and F) A single coiled body and three B-snurposomes 8 h after injection of
transcripts of myc-SLBP1-R, which consists of the RNA-binding domain alone. Staining is at background level. (G and H) A single coiled body
8 h after injection of transcripts of myc-SLBP1-RCD. This protein accumulates in the matrix of the coiled body despite lacking a functional
RNA-binding domain.
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(myc-SLBP1-NC, amino acids 1–122 1 196–253) also
failed to accumulate in any specific structure, suggest-
ing that either the entire protein was required for
targeting to coiled bodies or the necessary sequences
overlapped two or more regions covered by the dele-
tions. The latter turned out to be the case, because a
construct consisting of the RNA-binding domain and
the carboxy terminus (myc-SLBP1-RC, amino acids
123–253) accumulated within coiled bodies at levels
comparable with the full-length protein. As with full-
length myc-SLBP1, the staining pattern of myc-
SLBP1-RC was limited to the matrix of coiled bodies,
being excluded from the B-snurposomes on the sur-
face and the inclusions.
To determine whether a functional RNA-binding
domain was necessary for coiled body localization, we
deleted 17 additional amino acids from the RNA-
binding domain (myc-SLBP1-RCD, amino acids 140–
253). This construct also accumulated in coiled bodies
at a level similar to that of the full-length protein
(Figure 6, G and H). In their original study, Wang et al.
(1996) found that a deletion of just seven amino acids
from the amino end of the RNA-binding domain elim-
inated in vitro binding to the stem-loop structure.
Thus, targeting of SLBP1 to coiled bodies is not de-
pendent on an intact RNA-binding domain.
We looked for targeting of the deletion constructs to
terminal and axial granules, especially in the case of
Figure 7. (A) Full-length myc plus NLS–tagged SLBP1 and constructs were derived by deleting the amino terminus (amino acids 1–122), the
RNA-binding region (amino acids 123–195), or the carboxy terminus (amino acids 196–253), either singly or in pairs. Construct myc-SLBP1-
RCD had a further deletion of 17 amino acids from the left end of the RNA-binding region. The table on the right shows which constructs
were targeted to coiled bodies (CB). (B) In vitro transcripts were produced from clones encoding these constructs and were injected into the
cytoplasm of stage V–VI oocytes. GVs and cytoplasm (Cyt) were isolated 10 h later, and expressed proteins were detected on Western blots
with mAb 9E10 against the c-myc epitope. In each case a protein was detected in the GV, whereas little reactivity was seen in the cytoplasm.
All constructs included an SV40 NLS to ensure import into the GV. Construct myc-SLBP1-R has an anomalously low mobility.
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myc-SLBP1-RC and myc-SLBP1-RCD, which accumu-
late in coiled bodies. In no case did we see convincing
staining of the chromosomal granules. It is possible
that chromosomal targeting requires protein interac-
tions different from those involved in coiled body
localization. However, because high background
staining made targeting of even the full-length protein
to the chromosomes somewhat difficult to demon-
strate, failure to detect the deletion constructs may
have been attributable to insufficient sensitivity.
DISCUSSION
A polyclonal serum (X16C) raised against a carboxy-
terminal peptide from Xenopus SLBP1 showed strong
immunofluorescent staining of coiled bodies in spread
preparations of Xenopus GV contents. Staining was
markedly reduced by pretreatment of the antibody
with the peptide antigen against which it was raised.
Furthermore, when a myc-tagged SLBP1 transcript
was injected into the oocyte cytoplasm, newly trans-
lated SLBP1 was imported into the nucleus and tar-
geted to the coiled bodies. Other minor sites were
recognized by the antibody and by the tagged protein
(see below), but coiled bodies are the most prominent
structures in the GV that contain SLBP1. Coiled bodies
in the GV are variable in size, ranging up to 10 mm or
more in diameter, and they exhibit considerable sub-
structure that is not detectable in the much smaller
coiled bodies of somatic nuclei (Figure 1). Specifically,
coiled bodies in the GV often have one or more
smaller granules on their surface that are identical in
structure and composition to the many hundreds or
thousands of B-snurposomes present throughout the
GV. In addition, they may have one to many B-like
inclusions (Wu et al., 1991). Previous immunofluores-
cence and in situ hybridization studies demonstrated
sharp differences in the composition of these compo-
nents. The B-snurposomes and B-like inclusions con-
tain splicing factors (all five splicing snRNPs plus SR
proteins), whereas the body or matrix of the coiled
body contains the U7 snRNP and the coiled body–
specific marker protein p80-coilin (originally called
SPH-1 in Xenopus) (Wu et al., 1991, 1994; Tuma et al.,
1993; Wu and Gall, 1993; Gall et al., 1995; Bellini and
Gall, 1998).
Both the staining results and the targeting of myc-
tagged SLBP1 show that SLBP1 is colocalized with the
U7 snRNP and coilin in the matrix of coiled bodies.
Thus, the two major factors known to be necessary for
histone pre-mRNA processing occur together within
the same subcompartment of the coiled body. How-
ever, as can be seen in Figure 2, H and J, staining with
anti-SLBP1 serum has a distinctly mottled appearance
that is not apparent with either mAb Y12 (against Sm
proteins) or mAb K121 (against TMG), both of which
are markers for the U7 snRNP in the matrix of coiled
bodies (Bellini and Gall, 1998). Similarly, myc-SLBP1
that has been targeted to the matrix of the coiled body
has an inhomogeneous distribution, as visualized by
anti-myc antibody (Figure 6, A and G). Thus, it is
possible that SLBP1 and the U7 snRNP are not strictly
colocalized. On the other hand, electron micrographs
of the matrix (see Gall et al. [1995], their Figure 3) show
a relatively homogeneous population of 30- to 50-nm
particles, without much suggestion of higher order
substructure that would be resolvable by light micros-
copy.
Not only do coiled bodies contain the two major
components required for histone pre-mRNA process-
ing, but some coiled bodies are attached to lampbrush
chromosomes at the histone gene loci (Gall et al., 1981;
Callan et al., 1991). A similar preferential association of
coiled bodies with histone genes has been demon-
strated in HeLa cell nuclei (Frey and Matera, 1995).
Histone gene transcription in the GV takes place on
loops of the lampbrush chromosomes that are imme-
diately adjacent to the attached coiled bodies (Gall et
al., 1983; Diaz and Gall, 1985), but there is no evidence
that transcription occurs within the coiled bodies
themselves. These relationships suggest two possible,
nonexclusive functions for coiled bodies. The first is
that coiled bodies recruit SLBP1 and the U7 snRNP to
the sites of histone gene transcription. Such a role for
coiled bodies was first suggested by the targeting of
U7 snRNA to coiled bodies within minutes after injec-
tion into the cytoplasm of oocytes (Wu et al., 1996). The
targeting of myc-SLBP1 in the similar experiments re-
ported here is not so rapid, although this may reflect
the time required for translation of sufficient protein
from the injected transcripts or the sensitivity of the
assay. Another possible function for coiled bodies,
suggested by the presence of both SLBP1 and the U7
snRNP in the matrix, is the formation of a bifunctional
complex that would simultaneously engage the stem
loop and the U7-binding sequence of histone pre-
mRNA. In preliminary experiments we were unable to
demonstrate an interaction between SLBP1 and the U7
snRNP in nuclear extracts by coimmunoprecipitation
with anti-SLBP1 antibodies. Such a complex might
represent only a small fraction of the total SLBP1 in the
nucleus, or it might involve weak interactions that are
difficult to demonstrate. Both complications were en-
countered in a recent demonstration of interaction
between coilin and the U7 snRNP (Bellini and Gall,
1998). Alternatively, a stable complex between SLBP1
and the U7 snRNP may occur only in the presence of
histone pre-mRNA (Dominski, personal communica-
tion).
Only the carboxy-terminal third of the SLBP1 mol-
ecule is required for targeting to coiled bodies. Of
particular interest is the fact that a functional RNA-
binding domain is not needed. That is, an SLBP1 frag-
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ment that cannot interact with the stem loop of histone
pre-mRNA is targeted to the coiled body as well as the
full-length protein. Thus, SLBP1 does not need to en-
gage the histone pre-mRNA before it goes to the coiled
body. A similar situation exists for U7 snRNA, which
does not require its histone pre-mRNA–binding re-
gion for targeting to the coiled body (Wu et al., 1996).
It is possible, therefore, that both major factors in-
volved in histone pre-mRNA processing, SLBP1 and
U7 snRNA, may go to the coiled body before binding
to histone pre-mRNA.
The discussion to this point has focused on SLBP1 in
coiled bodies, especially those coiled bodies attached to
the chromosomes at the histone gene loci. A complete
account of SLBP1 in the GV must accommodate two
additional facts: first, that most of the 50–100 coiled
bodies in the GV are free in the nucleoplasm (not asso-
ciated with histone genes) and, second, that most SLBP1
in the GV is not in coiled bodies but in the “soluble”
phase of the nucleoplasm. The most probable explana-
tion is that much of the SLBP1 in the GV is not functional
in the sense of being actively engaged in histone pre-
mRNA processing but rather is being stored in the oo-
cyte for later use during embryogenesis (Wang et al.,
1999). Many other molecules in the GV, including com-
ponents of coiled bodies such as coilin (Bauer and Gall,
1997), the Sm proteins (Forbes et al., 1983; Zeller et al.,
1983; Fritz et al., 1984), and U7 snRNA (our unpublished
data), are in this category. Our interpretation is that the
small amount of SLBP1 in coiled bodies at the histone
gene loci represents active molecules about to be used
for histone pre-mRNA processing. A minute fraction of
the rest might represent SLBP1 associated with pro-
cessed transcripts that have yet to be exported, but a
major fraction of the SLBP1 in the nucleus is probably
there simply for storage.
An unexpected finding of this study was the stain-
ing of terminal granules, axial granules, and a few
chromosomal loops with the anti-SLBP1 antibody.
That the staining of terminal and axial granules is
caused by SLBP1 and not by cross-reaction or by con-
taminating antibodies is supported by the elimination
of staining by the SLBP1 peptide and the targeting of
myc-tagged SLBP1 to these same loci. The staining of
chromosomal loops is more difficult to interpret. Loop
staining was eliminated by the peptide, but myc-
tagged SLBP1 was not specifically targeted to these
loops. One possibility is that the positive loops do not
contain SLBP1 but another protein that shares an
epitope recognized by antibody X16C. Alternatively,
the myc-tagged SLBP1 protein may assume a confor-
mation that prevents it from being targeted appropri-
ately to the loops. In any case, the positive loops
represent a rare category of nascent transcripts that
are not stained by antibodies against splicing factors.
The terminal granules were shown previously to be
the sites of the 5S rRNA genes, and we know that the
U1 and U2 snRNA genes are located at X16C(1) axial
granules. All of these X16C(1) loci (the special loops
as well as the terminal and axial granules) represent
genes that produce unspliced transcripts. This finding
suggests that SLBP1 may have a role in RNA process-
ing unrelated to histone pre-mRNA. It will be inter-
esting to determine whether SLBP1 can bind to any of
these other RNA molecules and, if so, whether bind-
ing is mediated by a stem loop.
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